EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A

Ming Y Lim, Satoko Ito, George Goshua, Nathorn Chaiyakunapruk, Minkyoung Yoo, Richard Nelson

Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100195

DOI: 10.1016/j.bvth.2026.100195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Ming Y Lim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
  • Section of Medical Oncology and Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT.
  • Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT.
  • Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT.
  • Informatics, Decision-Enhancement, and Analytic Sciences Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT.
  • Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute
  • Yale Cancer Center
  • Frederick A. DeLuca Foundation

Zitieren

APA

Lim, M. Y., Ito, S., Goshua, G., Chaiyakunapruk, N., Yoo, M., & Nelson, R. (2026). Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100195. https://doi.org/10.1016/j.bvth.2026.100195

Vancouver

Lim MY, Ito S, Goshua G, Chaiyakunapruk N, Yoo M, Nelson R. Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100195. doi:10.1016/j.bvth.2026.100195

BibTeX
@article{Lim2026,
  author = {Lim, Ming Y and Ito, Satoko and Goshua, George and Chaiyakunapruk, Nathorn and Yoo, Minkyoung and Nelson, Richard},
  title = {Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A},
  journal = {Blood Vessels, Thrombosis & Hemostasis},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {100195},
  doi = {10.1016/j.bvth.2026.100195}
}
Kostenlos starten →